Two Sigma Securities’s Albany Molecular Research Inc AMRI Stock Holding History

Two Sigma Securities’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-25,071	Closed	-$544K	–	1375
2017 Q2	$544K	Buy	+25,071	New	+$455K	0.1%	190

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Two Sigma Securities's AMRI Position: Q3 2017 in Review

Two Sigma Securities sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 25,071 shares — an estimated $544K sold.

Two Sigma Securities first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $544K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Two Sigma Securities reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Two Sigma Securities sold 25,071 Albany Molecular Research Inc shares in Q3 2017, an estimated $544K.
Two Sigma Securities first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
Two Sigma Securities's Albany Molecular Research Inc position peaked at $544K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Two Sigma Securities's 13F filing for Q3 2017, filed 14 Nov 2017.